A
ACBM
vs
S&P 500
S&P 500
Over the past 12 months, ACBM has significantly outperformed S&P 500, delivering a return of +2 120% compared to the S&P 500's +21% growth.
Stocks Performance
ACBM vs S&P 500
Performance Gap
ACBM vs S&P 500
Performance By Year
ACBM vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
ACRO Biomedical Co Ltd
Glance View
Acro Biomedical Co. Ltd. engages in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. The company is headquartered in Fishers, Indiana. The company went IPO on 2016-06-23. The firm intends to conduct research and development on its products based on cordyceps sinensis. Cordyceps is a fungus that is used in traditional Chinese medicine. Cordyceps sinensis is a medicine in old Chinese medical books and Tibetan medicine. The company is a rare combination of a caterpillar and a fungus and found at altitudes above 4500meters in Sikkim. Its other products include Metallothionein, Marine elements, Embryonic Nutrients and Active Compound of Antrodia Cinnamomea. Metallothionein is a rare micro protein. Marine elements is a group of trace multi-peptides, also known as marine embryonic elements.
